CIRC (01763) Subsidiary Releases New Isotope Separation Technology for Advanced Nuclear Medicine and Controlled Nuclear Fusion

Stock News
10/17

CIRC (01763) announced that its subsidiary, Chengdu Nuclear High Technology Isotope Co., Ltd. (Nuclear High Technology), has officially launched a new isotope separation technology based on the fourth-generation "MOF" materials called 「Adsorption Catcher.」 This innovation aims to inject new momentum into the fields of advanced nuclear medicine and controlled nuclear fusion, paving the way for new industrial development prospects. The 「Adsorption Catcher」 technology innovatively incorporates fourth-generation "MOF" materials, which were highlighted in the 2025 Nobel Prize in Chemistry, breaking through the inherent framework of traditional isotope separation technologies and achieving "customized design" of separation materials at the molecular scale. The 「Adsorption Catcher」 technology showcases significant advantages, including "high purity, high efficiency, low cost, and low energy consumption." It has a wide range of applications covering key areas crucial to the national economy, such as nuclear medicine, nuclear fusion, heavy water reactors, and biomedical research. This development will provide core technological support for building a "self-controllable, safe, and stable" isotope supply chain in China, helping to reduce reliance on imported high-end isotopes.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10